As of 2024-12-14, the EV/EBITDA ratio of 4Basebio PLC (4BB.L) is -21.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 4BB.L's latest enterprise value is 196.12 mil GBP. 4BB.L's TTM EBITDA according to its financial statements is -9.04 mil GBP. Dividing these 2 quantities gives us the above 4BB.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.5x - 13.2x | 11.9x |
| Forward P/E multiples | 22.9x - 30.2x | 28.6x |
| Fair Price | (1,419.72) - (851.67) | (1,266.02) |
| Upside | -219.8% - -171.9% | -206.8% |
| Date | EV/EBITDA |
| 2024-12-11 | -21.95 |
| 2024-12-10 | -22.37 |
| 2024-12-09 | -22.80 |
| 2024-12-06 | -23.66 |
| 2024-12-05 | -23.66 |
| 2024-12-04 | -23.66 |
| 2024-12-03 | -23.66 |
| 2024-12-02 | -23.66 |
| 2024-11-29 | -23.66 |
| 2024-11-28 | -22.80 |
| 2024-11-27 | -22.46 |
| 2024-11-26 | -23.66 |
| 2024-11-25 | -23.66 |
| 2024-11-22 | -23.66 |
| 2024-11-21 | -23.66 |
| 2024-11-20 | -23.66 |
| 2024-11-19 | -23.66 |
| 2024-11-18 | -23.66 |
| 2024-11-15 | -24.09 |
| 2024-11-14 | -24.09 |
| 2024-11-13 | -24.09 |
| 2024-11-12 | -23.66 |
| 2024-11-11 | -23.23 |
| 2024-11-08 | -23.23 |
| 2024-11-07 | -23.23 |
| 2024-11-06 | -23.23 |
| 2024-11-05 | -23.23 |
| 2024-11-04 | -23.23 |
| 2024-11-01 | -22.97 |
| 2024-10-31 | -23.32 |
| 2024-10-30 | -23.32 |
| 2024-10-29 | -23.83 |
| 2024-10-28 | -24.51 |
| 2024-10-25 | -23.91 |
| 2024-10-24 | -23.91 |
| 2024-10-23 | -23.74 |
| 2024-10-22 | -23.57 |
| 2024-10-21 | -23.57 |
| 2024-10-18 | -23.57 |
| 2024-10-17 | -23.57 |
| 2024-10-16 | -23.57 |
| 2024-10-15 | -23.49 |
| 2024-10-14 | -23.66 |
| 2024-10-11 | -25.20 |
| 2024-10-10 | -25.20 |
| 2024-10-09 | -25.20 |
| 2024-10-08 | -25.20 |
| 2024-10-07 | -25.20 |
| 2024-10-04 | -25.20 |
| 2024-10-03 | -25.20 |